Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 125,000 LCTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 125,000 | n/a |
| Jun 18, 2026 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 39,453 | n/a |
| Jul 3, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 75,000 | n/a |
| Jun 25, 2025 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 42,833 | n/a |
| Aug 28, 2024 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 75,000 | n/a |
| Jul 3, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 75,000 | n/a |
| May 3, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 15,000 | n/a |
| Jul 3, 2023 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 50,000 | n/a |
| Oct 3, 2022 | TherapeuticsMD, Inc. (TXMD) | Grant/Award | 5,000 | n/a |
| Aug 22, 2022 | TherapeuticsMD, Inc. (TXMD) | Exercise/Conversion | 1,984 | n/a |